Cargando…

miR-125b and miR-532-3p predict the efficiency of rituximab-mediated lymphodepletion in chronic lymphocytic leukemia patients. A French Innovative Leukemia Organization study

The underlying in vivo mechanisms of rituximab action remain incompletely understood in chronic lymphocytic leukemia. Recent data suggest that circulating micro-ribonucleic acids correlate with chronic lymphocytic leukemia progression and response to rituximab. Our study aimed at identifying circula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gagez, Anne-Laure, Duroux-Richard, Isabelle, Leprêtre, Stéphane, Orsini-Piocelle, Frédérique, Letestu, Rémi, De Guibert, Sophie, Tuaillon, Edouard, Leblond, Véronique, Khalifa, Olfa, Gouilleux-Gruart, Valérie, Banos, Anne, Tournilhac, Olivier, Dupuis, Jehan, Jorgensen, Christian, Cartron, Guillaume, Apparailly, Florence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ferrata Storti Foundation 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395115/ https://www.ncbi.nlm.nih.gov/pubmed/28126961 http://dx.doi.org/10.3324/haematol.2016.153189

Ejemplares similares

miRNA profile at diagnosis predicts treatment outcome in patients with B-chronic lymphocytic leukemia: A FILO study
por: Duroux-Richard, Isabelle, et al.
Publicado: (2022)

Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups
por: Gagez, A-L, et al.
Publicado: (2016)

Clinical significance of miR-372 and miR-495 in acute myeloid leukemia
por: Zhang, Wei, et al.
Publicado: (2020)

miR-150: targeting MLL leukemia
por: Jiang, Xi, et al.
Publicado: (2012)

Circulating miR-92a, miR-143 and miR-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia
por: Elhamamsy, Amr Rafat, et al.
Publicado: (2017)

miR-1, miR-10b, miR-155, and miR-191 are novel regulators of BDNF
por: Varendi, Kärt, et al.
Publicado: (2014)

Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia
por: Fayyad-Kazan, Hussein, et al.
Publicado: (2013)

Differential Expression Profile of miR-27b, miR-29a, and miR-155 in Chronic Lymphocytic Leukemia and Breast Cancer Patients
por: Raeisi, Farzaneh, et al.
Publicado: (2020)

Association Analysis Between the Functional Single Nucleotide Variants in miR-146a, miR-196a-2, miR-499a, and miR-612 With Acute Lymphoblastic Leukemia
por: Jiménez-Morales, Silvia, et al.
Publicado: (2021)

Antileukemic Effects of Anti-miR-146a, Anti-miR-155, Anti-miR-181a, and Prednisolone on Childhood Acute Lymphoblastic Leukemia
por: Durmaz, Burak, et al.
Publicado: (2021)

Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia
por: Xu, Ling, et al.
Publicado: (2014)

Involvement of SNPs in miR-3117 and miR-3689d2 in childhood acute lymphoblastic leukemia risk
por: Gutierrez-Camino, Angela, et al.
Publicado: (2018)

MiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemia
por: Vargova, K, et al.
Publicado: (2017)

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients
por: Meng, Xiaodan, et al.
Publicado: (2015)

Targeting miR-126 in Ph+ acute lymphoblastic leukemia
por: Qiao, Junjing, et al.
Publicado: (2023)

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
por: Qiu, Shuwei, et al.
Publicado: (2013)

Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
por: Schee, Kristina, et al.
Publicado: (2012)

MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1
por: Sun, Yan-ping, et al.
Publicado: (2016)

Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer
por: Larki, Pegah, et al.
Publicado: (2018)

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2019)

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
por: Nemecz, Miruna, et al.
Publicado: (2023)

The miR-532-E2F1 feedback loop contributes to gastric cancer progression
por: Gao, Shanting, et al.
Publicado: (2022)

miR-532-3p inhibits the progression of tongue squamous cell carcinoma by targeting podoplanin
por: Liu, Zhi-Yun, et al.
Publicado: (2021)

NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia
por: Yang, Yu-Qiong, et al.
Publicado: (2018)

Diagnostic Value of Plasma miR-145 and miR-185 as Targeting of the APRIL Oncogene in the B-cell Chronic Lymphocytic Leukemia
por: Bagheri, Malihe, et al.
Publicado: (2021)

High expression of miR-107 and miR-17 predicts poor prognosis and guides treatment selection in acute myeloid leukemia
por: Liu, Yue, et al.
Publicado: (2023)

Elevated Serum miR-7, miR-9, miR-122, and miR-141 Are Noninvasive Biomarkers of Acute Pancreatitis
por: Lu, Pan, et al.
Publicado: (2017)

Metformin decreases miR-122, miR-223 and miR-29a in women with polycystic ovary syndrome
por: Udesen, Pernille Bækgaard, et al.
Publicado: (2020)

Prognostic value of miR-96 in patients with acute myeloid leukemia
por: Zhao, Jiangning, et al.
Publicado: (2014)

BIK is a novel pro-apoptotic target gene for miR-125b in human monocytes
por: Duroux-Richard, I, et al.
Publicado: (2010)

MiR-CLIP reveals iso-miR selective regulation in the miR-124 targetome
por: Wang, Yuluan, et al.
Publicado: (2020)

miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging
por: Hackl, Matthias, et al.
Publicado: (2010)

MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
por: Unterbruner, Kristoffer, et al.
Publicado: (2018)

The clinical significance of circulating miR-21, miR-142, miR-143, and miR-146a in patients with prostate cancer
por: Bolayırlı, Ibrahim Murat, et al.
Publicado: (2022)

miR-496, miR-1185, miR-654, miR-3183 and miR-495 are downregulated in colorectal cancer cells and have putative roles in the mTOR pathway
por: Alqurashi, Naif, et al.
Publicado: (2019)

Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia
por: Ngankeu, Apollinaire, et al.
Publicado: (2017)

Correlation between Circulating miR-16, miR-29a, miR-144 and miR-150, and the Radiotherapy Response and Survival of Non-Small-Cell Lung Cancer Patients
por: Bache, Matthias, et al.
Publicado: (2023)

Post-transcriptional Regulation of PCSK9 by miR-191, miR-222, and miR-224
por: Naeli, Parisa, et al.
Publicado: (2017)

FAIM Is Regulated by MiR-206, MiR-1-3p and MiR-133b
por: Coccia, Elena, et al.
Publicado: (2020)

Expression of miR-127, miR-154, and miR-183 in Medullary Thyroid Carcinoma Tumors
por: RAHMANI SAMANI, Mahsa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_svnkv1b05ojr494aguut2uep4q